Methods for treating patients having an early B cell derived acute lymphoblastic
leukemia with rapamycin or a derivative thereof are provided. Also provided are
methods for treating patients having an early B cell derived acute lymphoblastic
leukemia with rapamycin or a derivative thereof in combination with an IL-7 inhibitor.
Finally methods for preventing GVHD in ALL patients following a bone marrow transplant
are disclosed.